Education
About Us
Working with TipRanks
Follow Us
BeOne Medicines Ltd (HK:6160)
:6160
6160 Analyst Ratings
Strong Buy
4 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
6160 Stock 12 Month Forecast
Average Price Target
HK$241.82
▲(30.71% Upside)
| Highest Price TargetHK$290.00 | Average Price TargetHK$241.82 | Lowest Price TargetHK$212.09 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Unknown Analyst
BOCOM International Holdings CompanyNot Ranked
BOCOM International Holdings Company
HK$229.2
Buy
23.89%
Upside
Reiterated
03/02/26
DBS
HK$290
Buy
56.76%
Upside
Reiterated
02/27/26
Macquarie
HK$236
Buy
27.57%
Upside
Reiterated
12/09/25
CLSA
HK$288
Buy
55.68%
Upside
Reiterated
11/07/25
Unknown Analyst
HSBCNot Ranked
HSBC
HK$225→HK$222
Buy
20.00%
Upside
Reiterated
10/27/25
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Unknown Analyst
BOCOM International Holdings CompanyNot Ranked
BOCOM International Holdings Company
HK$229.2
Buy
23.89%
Upside
Reiterated
03/02/26
DBS
HK$290
Buy
56.76%
Upside
Reiterated
02/27/26
Macquarie
HK$236
Buy
27.57%
Upside
Reiterated
12/09/25
CLSA
HK$288
Buy
55.68%
Upside
Reiterated
11/07/25
Unknown Analyst
HSBCNot Ranked
HSBC
HK$225→HK$222
Buy
20.00%
Upside
Reiterated
10/27/25
Best Analysts Covering BeOne Medicines Ltd
3 Months
xxx
Success Rate
6/10 ratings generated profit
Average Return
+1.26%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 60.00% of your transactions generating a profit, with an average return of +1.26% per trade.
1 Year
Success Rate
8/10 ratings generated profit
Average Return
+30.65%
reiterated a buy rating 4 months ago
Copying Matthew Yan's trades and holding each position for 1 Year would result in 80.00% of your transactions generating a profit, with an average return of +30.65% per trade.
2 Years
xxx
Success Rate
10/10 ratings generated profit
Average Return
+50.25%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +50.25% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
6160 Analyst Recommendation Trends
Rating
Nov 25
Dec 25
Jan 26
Feb 26
Mar 26
Strong Buy
1
1
1
1
1
Buy
18
17
13
4
3
Hold
11
22
21
16
11
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
30
40
35
21
15
Each month's total comprises the sum of three months' worth of ratings.
6160 Financial Forecast
6160 Stock Forecast FAQ
What is HK:6160’s average 12-month price target, according to analysts?
Based on analyst ratings, BeOne Medicines Ltd’s 12-month average price target is 241.82.
What is HK:6160’s upside potential, based on the analysts’ average price target?
BeOne Medicines Ltd has 30.71% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is BeOne Medicines Ltd a Buy, Sell or Hold?
BeOne Medicines Ltd has a consensus rating of Strong Buy, which is based on 4 buy ratings, 0 hold ratings and 0 sell ratings.
What is BeOne Medicines Ltd’s share price target?
The average share price target for BeOne Medicines Ltd is 241.82. This is based on 4 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is HK$290.00 ,and the lowest forecast is HK$212.09. The average share price target represents 30.71% Increase from the current price of HK$185.
The highest analyst share price target is HK$290.00 ,and the lowest forecast is HK$212.09. The average share price target represents 30.71% Increase from the current price of HK$185.
What do analysts say about BeOne Medicines Ltd?
BeOne Medicines Ltd’s analyst rating consensus is a Strong Buy. This is based on the ratings of 4 Wall Streets Analysts.
How can I buy shares of BeOne Medicines Ltd?
To buy shares of HK:6160, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.